Text Size

Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Bayside Health.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Bayside Health
ClinicalTrials.gov Identifier:
NCT00157144
First received: September 9, 2005
Last updated: February 27, 2006
Last verified: September 2005
History of Changes
  Purpose

Extracorporeal membrane oxygenation (ECMO) is a means of artificially performing the function of the human lung and/or heart outside the body. Its use is escalating in a wide range of clinical settings in the adult population without evidence or guidelines to support this practice.

This study involves a nationwide questionnaire which has two components. The initial pilot survey will attempt to identify all institutions currently practicing ECMO or those intending to do so in the future, and are willing to participate in prospective data collection. The second phase will involve a monthly survey of these centres regarding the extent of ECMO use, practice details implemented, and outcome data.

It is hoped that the collection of this information will later assist in the development of guidelines for this expensive and presently unsubstantiated practice, together with the construction of appropriate training programs for staff.


Condition
Respiratory Distress Syndrome, Adult
Respiratory Insufficiency
Shock, Cardiogenic

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Retrospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Bayside Health:

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients receiving ECMO in Australia and New Zealand
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00157144

Contacts
Contact: Vincent A Pellegrino, MBBS +61 3 92763036 ext 2606 v.pelligrino@alfred.org.au

Locations
Australia, Victoria
Alfred Hospital Recruiting
Melbourne, Victoria, Australia, 3004
Contact: Vincent A Pellegrino, MBBS     +61 3 92763036 ext 2606     v.pelligrino@alfred.org.au    
Sponsors and Collaborators
Bayside Health
Investigators
Principal Investigator: Vincent A Pellegrino, MBBS National Health and Medical Research Council, Australia
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00157144     History of Changes
Other Study ID Numbers: 186/04
Study First Received: September 9, 2005
Last Updated: February 27, 2006
Health Authority: Australia: National Health and Medical Research Council

Keywords provided by Bayside Health:
Lung Transplantation
Heart Transplantation

Additional relevant MeSH terms:
Respiratory Distress Syndrome, Newborn
Respiratory Distress Syndrome, Adult
Acute Lung Injury
Respiratory Insufficiency
Shock, Cardiogenic
Lung Diseases
Respiratory Tract Diseases
Respiration Disorders
Infant, Premature, Diseases
 Infant, Newborn, Diseases
Lung Injury
Myocardial Infarction
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Shock
Pathologic Processes

ClinicalTrials.gov processed this record on May 23, 2013